Dan Tran, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 7900 Garvey Ave, Rosemead, CA 91770 Phone: 626-307-1050 Fax: 626-307-1051 |
News Archive
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
In this "End The Neglect" blog post, Ann Kelly, representative of the Howard G. Buffett Foundation's Global Water Initiative and co-founder of Partner at Global Philanthropy Group, provides an overview of a Global Network for Neglected Tropical Diseases co-hosted seminar at World Water Week in Stockholm, Sweden.
Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system.
Dyadem today announced the opening of its second office in Europe; located in Starnberg, Germany, on the outskirts of Munich. Dyadem, the leader in Operational and Quality Risk Management, has expanded in response to a surge in customer demand in the European Union for its enterprise risk management software and services amid heightened scrutiny of safety and quality standards for companies in the oil & gas, chemical, medical device and pharmaceutical industries.
› Verified 8 days ago